Your browser doesn't support javascript.
Detecting time-evolving phenotypic components of adverse reactions against BNT162b2 SARS-CoV-2 vaccine via non-negative tensor factorization.
Ikeda, Kei; Nakada, Taka-Aki; Kageyama, Takahiro; Tanaka, Shigeru; Yoshida, Naoki; Ishikawa, Tetsuo; Goshima, Yuki; Otaki, Natsuko; Iwami, Shingo; Shimamura, Teppei; Taniguchi, Toshibumi; Igari, Hidetoshi; Hanaoka, Hideki; Yokote, Koutaro; Tsuyuzaki, Koki; Nakajima, Hiroshi; Kawakami, Eiryo.
  • Ikeda K; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Nakada TA; Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Kageyama T; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Tanaka S; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Yoshida N; Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Ishikawa T; Advanced Data Science Project (ADSP), RIKEN Information R&D and Strategy Headquarters, Yokohama, Kanagawa 230-0045, Japan.
  • Goshima Y; Advanced Data Science Project (ADSP), RIKEN Information R&D and Strategy Headquarters, Yokohama, Kanagawa 230-0045, Japan.
  • Otaki N; Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
  • Iwami S; Interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Aichi 464-8602, Japan.
  • Shimamura T; Institute of Mathematics for Industry, Kyushu University, Fukuoka 819-0395, Japan.
  • Taniguchi T; Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Sakyo Ward, Kyoto 606-8501, Japan.
  • Igari H; Interdisciplinary Theoretical and Mathematical Sciences Program (iTHEMS), RIKEN, Wako, Saitama 351-0198, Japan.
  • Hanaoka H; NEXT-Ganken Program, Japanese Foundation for Cancer Research (JFCR), Koto Ward, Tokyo 135-8550, Japan.
  • Yokote K; Science Groove Inc., Fukuoka 810-0041, Japan.
  • Tsuyuzaki K; Division of Systems Biology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.
  • Nakajima H; Department of Infectious Diseases, Chiba University Hospital, Chiba University, Chiba 260-8670, Japan.
  • Kawakami E; Department of Infectious Diseases, Chiba University Hospital, Chiba University, Chiba 260-8670, Japan.
iScience ; 25(10): 105237, 2022 Oct 21.
Article in English | MEDLINE | ID: covidwho-2122545
ABSTRACT
Symptoms of adverse reactions to vaccines evolve over time, but traditional studies have focused only on the frequency and intensity of symptoms. Here, we attempt to extract the dynamic changes in vaccine adverse reaction symptoms as a small number of interpretable components by using non-negative tensor factorization. We recruited healthcare workers who received two doses of the BNT162b2 mRNA COVID-19 vaccine at Chiba University Hospital and collected information on adverse reactions using a smartphone/web-based platform. We analyzed the adverse-reaction data after each dose obtained for 1,516 participants who received two doses of vaccine. The non-negative tensor factorization revealed four time-evolving components that represent typical temporal patterns of adverse reactions for both doses. These components were differently associated with background factors and post-vaccine antibody titers. These results demonstrate that complex adverse reactions against vaccines can be explained by a limited number of time-evolving components identified by tensor factorization.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: IScience Year: 2022 Document Type: Article Affiliation country: J.isci.2022.105237

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: IScience Year: 2022 Document Type: Article Affiliation country: J.isci.2022.105237